Document is current
Any future updates will be listed below
-
Authors
Wu, Lingling
Zhu, Xiang
Liu, Yanxia
Zhao, Dehua
Yu, Betty Chentzu
Wei, Zheng
Lin, Xueqiu
Qi, Lei S.
- License Information
-
More Information
Article History
Received: 8 June 2024
Accepted: 3 July 2025
First Online: 6 August 2025
Declarations
:
: Primary human adipose-derived stem cells were obtained from Lifeline Cell Technology, a commercial vendor that collects human tissue under informed consent in compliance with the Declaration of Helsinki, HIPAA (Health Insurance Portability and Accountability Act of 1996), the Human Tissue Act (UK), and U.S. Code of Federal Regulations Title 21 (21 CFR 1270 and 1271). All donor tissues were fully de-identified and obtained through IRB-compliant tissue acquisition networks. No new human participants were recruited or involved in this study.
: Not applicable. This study does not contain any individual personal data.
: L.S.Q. is a founder of Epicrispr Biotechnologies and a scientific advisor of Laboratory of Genomic Research. This is unrelated to this study. X.Z. is employed by Calico Life Sciences, but completed the research for this work prior to this employment. Other authors declare no competing financial interests.
